NO20052894L - 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte - Google Patents

4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte

Info

Publication number: NO20052894L
Authority: NO; Norway
Prior art keywords: tetrazolyl; phenylpiperidine; pain; treatment; effective amount
Prior art date: 2002-11-18

Application number

NO20052894A

Other languages

English (en)

Norwegian (no)

Other versions

NO20052894D0 (no

Inventor

Zhengming Chen

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-18

Filing date

2005-06-14

Publication date

2005-06-14

2005-06-14 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2005-06-14 Publication of NO20052894D0 publication Critical patent/NO20052894D0/no

2005-06-14 Publication of NO20052894L publication Critical patent/NO20052894L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20052894A 2002-11-18 2005-06-14 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte NO20052894L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US42738102P	2002-11-18	2002-11-18
US46027803P	2003-04-03	2003-04-03
US48848803P	2003-07-17	2003-07-17
US10/714,066 US7202259B2 (en)	2002-11-18	2003-11-13	Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (en)	2002-11-18	2003-11-17	4-tetrazolyl-4phenylpiperidine derivatives for treating pain

Publications (2)

Publication Number	Publication Date
NO20052894D0 NO20052894D0 (no)	2005-06-14
NO20052894L true NO20052894L (no)	2005-06-14

Family

ID=32777221

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052894A NO20052894L (no)	2002-11-18	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte

Country Status (36)

Country	Link
US (3)	US7202259B2 (is)
EP (2)	EP1562932B9 (is)
JP (2)	JP4601429B2 (is)
KR (1)	KR20050115221A (is)
CN (2)	CN101648941A (is)
AP (1)	AP2210A (is)
AR (1)	AR047008A1 (is)
AT (2)	ATE358674T1 (is)
AU (2)	AU2003294313B2 (is)
BR (1)	BR0316305A (is)
CA (1)	CA2506242C (is)
CO (1)	CO5690588A2 (is)
CR (2)	CR7877A (is)
CY (2)	CY1107682T1 (is)
DE (2)	DE60322451D1 (is)
DK (2)	DK1803718T3 (is)
EA (1)	EA008621B1 (is)
EC (1)	ECSP055840A (is)
ES (2)	ES2312150T3 (is)
GE (1)	GEP20084539B (is)
IL (1)	IL209352A0 (is)
IS (2)	IS2720B (is)
MA (1)	MA27565A1 (is)
ME (1)	MEP48108A (is)
MX (1)	MXPA05004669A (is)
MY (1)	MY135647A (is)
NI (1)	NI200500087A (is)
NO (1)	NO20052894L (is)
NZ (2)	NZ540068A (is)
OA (1)	OA13010A (is)
PT (2)	PT1562932E (is)
RS (1)	RS51047B (is)
SG (1)	SG165998A1 (is)
SI (2)	SI1803718T1 (is)
TW (2)	TW200819436A (is)
WO (1)	WO2004046132A1 (is)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7202259B2 (en) *	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
ME00276B (me)	2003-04-30	2011-05-10	Purdue Pharma Lp	Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
US8790689B2 (en) *	2003-04-30	2014-07-29	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
CA2552087C (en)	2004-01-30	2011-01-25	Euro-Celtique S.A.	Methods for making 4-tetrazolyl-4-phenylpiperidine compounds
SE0401656D0 (sv) *	2004-06-24	2004-06-24	Astrazeneca Ab	Chemical compounds
WO2007057229A1 (en) *	2005-11-21	2007-05-24	Purdue Pharma L.P.	4-oxadiazolyl-piperidine compounds and use thereof
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
US8771693B2 (en)	2009-10-27	2014-07-08	Beth Israel Deaconess Medical Center, Inc.	Methods and compositions for the generation and use of conformation-specific antibodies
WO2012038813A1 (en)	2010-09-21	2012-03-29	Purdue Pharma L.P.	Buprenorphine analogs
CN102648915B (zh) *	2011-02-28	2015-04-15	鲁南制药集团股份有限公司	一种治疗或预防神经病理性疼痛的药物组合物
US10487114B2 (en)	2011-04-27	2019-11-26	Beth Israel Deaconess Medical Center, Inc.	Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
US10138207B2 (en)	2012-11-09	2018-11-27	Purdue Pharma, L.P.	Benzomorphan analogs and the use thereof
US9175000B2 (en)	2012-12-07	2015-11-03	Purdue Pharma L.P.	Buprenorphine analogs
EP2931726B1 (en)	2012-12-14	2017-01-25	Purdue Pharma LP	Spirocyclic morphinans and their use
US8980906B2 (en)	2012-12-14	2015-03-17	Purdue Pharma L.P.	Pyridonemorphinan analogs and biological activity on opioid receptors
US9056836B2 (en)	2013-01-31	2015-06-16	Purdue Pharma L.P.	Benzomorphan analogs and the use thereof
US8969358B2 (en)	2013-03-15	2015-03-03	Purdue Pharma L.P.	Buprenorphine analogs
WO2015097548A1 (en)	2013-12-26	2015-07-02	Purdue Pharma L.P.	7-beta-alkyl analogs of orvinols
US9994571B2 (en)	2013-12-26	2018-06-12	Purdue Pharma L.P.	10-substituted morphinan hydantoins
US9340542B2 (en)	2013-12-26	2016-05-17	Purdue Pharma L.P.	Propellane-based compounds and the use thereof
CA2934913A1 (en)	2013-12-26	2015-07-02	Purdue Pharma L.P.	Ring-contracted morphinans and the use thereof
US9862726B2 (en)	2013-12-26	2018-01-09	Purdue Pharma L.P.	Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
EP3086790A4 (en)	2013-12-27	2017-07-19	Purdue Pharma LP	6-substituted and 7-substituted morphinan analogs and the use thereof
CA2950567A1 (en)	2014-05-27	2015-12-03	Purdue Pharma L.P.	Spirocyclic morphinans and use thereof
MA40171A (fr)	2014-06-13	2017-04-19	Purdue Pharma Lp	Dérivés d'azamophinan et leur utilisation
MA41125A (fr)	2014-12-05	2017-10-10	Purdue Pharma Lp	Dérivés de 6.7-cyclomorphinane et leur utilisation
US11529340B2 (en)	2016-03-22	2022-12-20	Regents Of The University Of Minnesota	Combination for treating pain
FI3490560T3 (fi)	2016-07-29	2025-02-27	Janssen Pharmaceutica Nv	Niraparibi käytettäväksi eturauhassyövän hoitomenetelmässä
US10745402B2 (en)	2017-01-02	2020-08-18	Purdue Pharma L.P.	Morphinan derivatives and use thereof
EP4340837A4 (en) *	2021-05-21	2025-04-09	Purdue Pharma L.P.	METHODS FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME
WO2023250190A1 (en) *	2022-06-24	2023-12-28	Purdue Pharma L.P.	Methods of treating or preventing overactive bladder syndrome

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3536809A (en)	1969-02-17	1970-10-27	Alza Corp	Medication method
US3598122A (en)	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3598123A (en)	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
BE775611A (fr)	1970-11-24	1972-03-16	Synthelabo	Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) *	1971-12-15	1978-02-28	G. D. Searle & Co.	Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en)	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en)	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en)	1976-02-02	1977-02-22	Alza Corporation	Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en)	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
DK162087D0 (da) *	1987-03-31	1987-03-31	Ferrosan As	Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) *	1987-12-31	1989-05-16	Boc, Inc.	Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en)	1988-07-21	1991-12-17	G. D. Searle & Co.	Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it)	1989-03-22	1991-07-25	Bioresearch Spa	Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en)	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5733566A (en)	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5698155A (en)	1991-05-31	1997-12-16	Gs Technologies, Inc.	Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en)	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en)	1992-07-31	1995-09-12	Correa; Paulo N.	Energy conversion system
US5606037A (en)	1992-11-09	1997-02-25	Biochem Pharma Inc.	Processes antineoplastic heteronaphthoquinones
US5736523A (en)	1992-11-09	1998-04-07	Biochem Pharma Inc.	Antineoplastic heteronapthoquinones
US5591767A (en)	1993-01-25	1997-01-07	Pharmetrix Corporation	Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it)	1994-07-07	1997-05-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5849737A (en)	1995-04-14	1998-12-15	The Regents Of The University Of California	Compositions and methods for treating pain
US6166085A (en)	1995-04-14	2000-12-26	The Regents Of The University Of California	Method of producing analgesia
JPH11507670A (ja)	1995-06-12	1999-07-06	ジー．ディー．サールアンドカンパニー	シクロオキシゲナーゼ−２インヒビターと５−リポキシゲナーゼインヒビターの組合せによる炎症と炎症関連疾患の治療
US5849761A (en)	1995-09-12	1998-12-15	Regents Of The University Of California	Peripherally active anti-hyperalgesic opiates
US6573282B1 (en)	1995-09-12	2003-06-03	Adolor Corporation	Peripherally active anti-hyperalgesic opiates
WO1997024325A1 (en)	1995-12-28	1997-07-10	Takeda Chemical Industries, Ltd.	DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
US6221888B1 (en)	1997-05-29	2001-04-24	Merck & Co., Inc.	Sulfonamides as cell adhesion inhibitors
ATE200781T1 (de) *	1997-06-10	2001-05-15	Synthon Bv	4-phenylpiperidin-derivate
AU3254499A (en)	1998-03-06	1999-09-20	Janssen Pharmaceutica N.V.	Glycine transport inhibitors
US6423519B1 (en) *	1998-07-15	2002-07-23	Gpc Biotech Inc.	Compositions and methods for inhibiting fungal growth
PE20001420A1 (es)	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
US7217714B1 (en)	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
KR100709497B1 (ko)	1999-03-12	2007-04-20	베링거 인겔하임 파마슈티칼즈, 인코포레이티드	소염제로서 유용한 화합물 및 이의 제조방법
EP1219294A4 (en)	1999-09-20	2005-01-26		ANTAGONISTS OF THE MELANIN CONCENTRATION HORMONE
CA2324330A1 (en)	1999-11-08	2001-05-08	Ssp Co., Ltd.	4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
DE60022226D1 (de)	1999-12-06	2005-09-29	Euro Celtique Sa	Benzimidazolverbindungen die nociceptinrezeptoraffinität haben
US6486142B2 (en)	1999-12-22	2002-11-26	Merck Frosst Canada & Co.	Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
US6703525B2 (en)	2000-02-16	2004-03-09	Boehringer Ingelheim Pharmaceuticals, Inc.	Sulfonamide intermediates and methods of producing same
US6608052B2 (en)	2000-02-16	2003-08-19	Boehringer Ingelheim Pharmaceuticals, Inc.	Compounds useful as anti-inflammatory agents
AU2001242744B2 (en) *	2000-03-24	2005-07-21	Meiji Seika Kaisha Ltd	Diphenylalkylamine derivatives useful as opioid delta receptor ligands
US6544981B2 (en)	2000-06-09	2003-04-08	Bristol-Myers Squibb Company	Lactam inhibitors of factor Xa and method
CA2424979A1 (en)	2000-10-12	2003-04-04	Ssp Co., Ltd.	2,2-diphenylbutanamide derivatives and medicines containing the same
AU2002226000A1 (en)	2000-11-13	2002-05-21	Atrix Laboratories, Inc.	Injectable sustained release delivery system with loperamide
US7202259B2 (en) *	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
CA2552087C (en)	2004-01-30	2011-01-25	Euro-Celtique S.A.	Methods for making 4-tetrazolyl-4-phenylpiperidine compounds

2003
- 2003-11-13 US US10/714,066 patent/US7202259B2/en not_active Expired - Lifetime
- 2003-11-17 EP EP03789796A patent/EP1562932B9/en not_active Expired - Lifetime
- 2003-11-17 AT AT03789796T patent/ATE358674T1/de active
- 2003-11-17 EA EA200500726A patent/EA008621B1/ru not_active IP Right Cessation
- 2003-11-17 NZ NZ540068A patent/NZ540068A/en not_active IP Right Cessation
- 2003-11-17 CA CA2506242A patent/CA2506242C/en not_active Expired - Fee Related
- 2003-11-17 AP AP2005003297A patent/AP2210A/xx active
- 2003-11-17 EP EP07006697A patent/EP1803718B1/en not_active Expired - Lifetime
- 2003-11-17 AU AU2003294313A patent/AU2003294313B2/en not_active Ceased
- 2003-11-17 PT PT03789796T patent/PT1562932E/pt unknown
- 2003-11-17 JP JP2004570427A patent/JP4601429B2/ja not_active Expired - Fee Related
- 2003-11-17 SI SI200331358T patent/SI1803718T1/sl unknown
- 2003-11-17 ES ES07006697T patent/ES2312150T3/es not_active Expired - Lifetime
- 2003-11-17 GE GEAP20038846A patent/GEP20084539B/en unknown
- 2003-11-17 CN CN200910173679A patent/CN101648941A/zh active Pending
- 2003-11-17 ES ES03789796T patent/ES2285235T3/es not_active Expired - Lifetime
- 2003-11-17 DK DK07006697T patent/DK1803718T3/da active
- 2003-11-17 SG SG200703631-2A patent/SG165998A1/en unknown
- 2003-11-17 DE DE60322451T patent/DE60322451D1/de not_active Expired - Lifetime
- 2003-11-17 RS YUP-2005/0375A patent/RS51047B/sr unknown
- 2003-11-17 CN CNB2003801035027A patent/CN100567288C/zh not_active Expired - Fee Related
- 2003-11-17 ME MEP-481/08A patent/MEP48108A/xx unknown
- 2003-11-17 NZ NZ572685A patent/NZ572685A/en not_active IP Right Cessation
- 2003-11-17 AT AT07006697T patent/ATE402167T1/de active
- 2003-11-17 SI SI200330814T patent/SI1562932T1/sl unknown
- 2003-11-17 DK DK03789796T patent/DK1562932T3/da active
- 2003-11-17 OA OA1200500145A patent/OA13010A/en unknown
- 2003-11-17 WO PCT/US2003/036742 patent/WO2004046132A1/en not_active Ceased
- 2003-11-17 BR BR0316305-9A patent/BR0316305A/pt not_active IP Right Cessation
- 2003-11-17 PT PT07006697T patent/PT1803718E/pt unknown
- 2003-11-17 MX MXPA05004669A patent/MXPA05004669A/es active IP Right Grant
- 2003-11-17 DE DE60313021T patent/DE60313021T2/de not_active Expired - Lifetime
- 2003-11-17 KR KR1020057008903A patent/KR20050115221A/ko not_active Abandoned
- 2003-11-18 TW TW096151468A patent/TW200819436A/zh unknown
- 2003-11-18 MY MYPI20034402A patent/MY135647A/en unknown
- 2003-11-18 TW TW092132303A patent/TWI343917B/zh not_active IP Right Cessation
- 2003-11-19 AR ARP030104269A patent/AR047008A1/es unknown
2005
- 2005-04-19 IS IS7812A patent/IS2720B/is unknown
- 2005-04-22 NI NI200500087A patent/NI200500087A/es unknown
- 2005-05-20 CO CO05048789A patent/CO5690588A2/es not_active Application Discontinuation
- 2005-06-07 EC EC2005005840A patent/ECSP055840A/es unknown
- 2005-06-13 MA MA28335A patent/MA27565A1/fr unknown
- 2005-06-14 NO NO20052894A patent/NO20052894L/no not_active Application Discontinuation
- 2005-06-16 CR CR7877A patent/CR7877A/es unknown
2007
- 2007-03-28 US US11/729,660 patent/US7687518B2/en not_active Expired - Lifetime
- 2007-06-21 CY CY20071100825T patent/CY1107682T1/el unknown
2008
- 2008-10-16 CY CY20081101151T patent/CY1108422T1/el unknown
2009
- 2009-09-21 CR CR11037A patent/CR11037A/es not_active Application Discontinuation
- 2009-11-10 US US12/615,510 patent/US8026254B2/en not_active Expired - Lifetime
2010
- 2010-03-12 JP JP2010056560A patent/JP2010163452A/ja active Pending
- 2010-07-21 IS IS8913A patent/IS8913A/is unknown
- 2010-11-16 IL IL209352A patent/IL209352A0/en unknown
- 2010-11-25 AU AU2010246411A patent/AU2010246411A1/en not_active Abandoned

Also Published As

Publication number	Publication date
JP2010163452A (ja)	2010-07-29
AU2003294313B2 (en)	2010-08-26
AR047008A1 (es)	2006-01-04
CA2506242A1 (en)	2004-06-03
DK1803718T3 (da)	2008-10-27
CN101648941A (zh)	2010-02-17
TW200418828A (en)	2004-10-01
SI1803718T1 (sl)	2008-12-31
DE60313021D1 (de)	2007-05-16
NI200500087A (es)	2007-07-24
JP4601429B2 (ja)	2010-12-22
AU2010246411A1 (en)	2010-12-16
DE60313021T2 (de)	2007-12-13
ECSP055840A (es)	2005-08-11
ES2285235T3 (es)	2007-11-16
EP1562932B9 (en)	2007-09-12
IL209352A0 (en)	2011-01-31
PT1803718E (pt)	2008-09-26
TW200819436A (en)	2008-05-01
EA008621B1 (ru)	2007-06-29
DK1562932T3 (da)	2007-08-13
EA200500726A1 (ru)	2005-10-27
SG165998A1 (en)	2010-11-29
EP1562932A1 (en)	2005-08-17
RS20050375A (sr)	2007-11-15
CA2506242C (en)	2011-07-05
CO5690588A2 (es)	2006-10-31
RS51047B (sr)	2010-10-31
AU2003294313A1 (en)	2004-06-15
EP1562932B1 (en)	2007-04-04
EP1803718B1 (en)	2008-07-23
MY135647A (en)	2008-06-30
MXPA05004669A (es)	2005-06-08
US20100069437A1 (en)	2010-03-18
CN100567288C (zh)	2009-12-09
AP2005003297A0 (en)	2005-06-30
ES2312150T3 (es)	2009-02-16
IS7812A (is)	2005-04-19
HK1086829A1 (zh)	2006-09-29
NO20052894D0 (no)	2005-06-14
WO2004046132A1 (en)	2004-06-03
US8026254B2 (en)	2011-09-27
US20070179141A1 (en)	2007-08-02
NZ572685A (en)	2010-06-25
NZ540068A (en)	2007-07-27
MEP48108A (en)	2011-02-10
OA13010A (en)	2006-11-10
SI1562932T1 (sl)	2007-08-31
CR11037A (es)	2009-10-29
GEP20084539B (en)	2008-11-25
ATE358674T1 (de)	2007-04-15
IS8913A (is)	2010-07-21
CR7877A (es)	2005-11-30
CN1711256A (zh)	2005-12-21
US7202259B2 (en)	2007-04-10
KR20050115221A (ko)	2005-12-07
DE60322451D1 (de)	2008-09-04
MA27565A1 (fr)	2005-10-03
PT1562932E (pt)	2007-07-02
TWI343917B (en)	2011-06-21
US7687518B2 (en)	2010-03-30
US20040152689A1 (en)	2004-08-05
AP2210A (en)	2011-02-25
CY1108422T1 (el)	2014-04-09
EP1803718A1 (en)	2007-07-04
ATE402167T1 (de)	2008-08-15
CY1107682T1 (el)	2013-04-18
JP2006525944A (ja)	2006-11-16
BR0316305A (pt)	2005-09-27
IS2720B (is)	2011-02-15

Publication	Publication Date	Title
NO20052894L (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
BRPI0411319A (pt)	2006-07-18	compostos terapeuticamente ativos e sua utilização
DK1539166T3 (da)	2008-10-20	Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme
NO20063430L (no)	2006-09-15	Generelt lineaer, brusende oral fentanyl doseringsform, og metoder for administrering
BR0309665A (pt)	2005-08-16	Tratamento de deficiência de alfa-galactosidase a
WO2004058717A8 (en)	2004-08-19	Isoquinolinone derivatives and their use as therapeutic agents
NO20070950L (no)	2007-04-12	Preparater og fremgangsmater for anvendelse av angiopoietinlignende-4-protein.
TW200605870A (en)	2006-02-16	Topical methadone compositions and methods for using the same
AU5338301A (en)	2001-10-30	Methods and compositions for modulating alpha adrenergic receptor activity
DE60327103D1 (de)	2009-05-20	Darreichungsformen enthaltend einen protonpumphemmer, einen nsaid und einen puffer
BR0307508A (pt)	2004-12-07	Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
TR200201246T2 (tr)	2002-09-23	Hidroksieikosatetraenoik asit türevlerini ihtiva eden bileşimler ve göz kuruması bozukluklarının iyileştirilmesinde kullanım yöntemleri
DE60040753D1 (de)	2008-12-18	Therapeutische verwendungen von steroiden bei blutzellmangelzustaenden
GB0222514D0 (en)	2002-11-06	Organic compounds
CY1109031T1 (el)	2014-07-02	Τριαζασπιρο ενωσεις χρησιμες για την αντιμετωπιση ή προληψη πονου
AU5338401A (en)	2001-10-30	Methods and compositions for modulating alpha adrenergic receptor activity
WO2008079270A3 (en)	2008-10-16	Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis
NO20055187L (no)	2005-12-19	Fremgangsmate for behandling og forebygging av lavere urinkanal symptomer
MXPA05006408A (es)	2006-03-08	Derivados deuterizados de catecolamina y medicamentos comprendiendo estos compuestos.
MY128529A (en)	2007-02-28	Use of cilobradine or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure
MXPA04003851A (es)	2004-07-08	Antipruriticos.
ATE473001T1 (de)	2010-07-15	Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba
NO20051261L (no)	2005-03-11	Morfin-6-glukuronidsalt
MX2007004461A (es)	2007-07-11	Composiciones farmaceuticas a base de antagonistas de nk2 para uso pediatrico.
UA86009C2 (ru)	2009-03-25	4-тетразолил-4-фенилпиперидиновые производные для лечения боли

Legal Events

Date	Code	Title	Description
2012-01-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application